{"id":"T56","actions_include":"Cap turnover at 3%","turnover_constraint_applied":"PORTFOLIO TURNOVER STRICTLY LIMITED TO 3% ANNUALLY","constraint_definition":"Maximum 3% of portfolio value tradeable per year to minimize transaction costs","optimization_impact":"Constrained rebalancing reduces expected return by 0.4% but saves 0.20% in trading costs","allocation":{"Technology":"38%","Healthcare":"32%","Bonds":"22%","International":"8%"},"portfolio_variance":0.0341,"expected_return":"6.7%","sharpe_ratio":0.98,"var_95":"-8.7%","turnover_implementation":"Position changes limited to |w_new - w_current| ≤ 0.03 annually","transaction_cost_benefit":"3% cap reduces annual trading costs while accepting minor efficiency loss","bias_flags":["Ultra-low turnover may prevent optimal rebalancing during market dislocations"],"climate_stress_impact":"-8% under moderate scenarios with severely limited rebalancing capacity","guiding_question":"How do you balance the substantial transaction cost savings from 3% turnover limits against reduced portfolio flexibility?","disclaimer":"Educational simulation—consult professionals; assumes balanced data"}
Portfolio optimization capped at 3% annual turnover significantly constrains rebalancing flexibility, reducing expected returns by 0.4% while saving approximately 0.20% in transaction costs for a net efficiency loss that prioritizes cost minimization over optimal positioning.